Global scale Antares Vision Group operates worldwide with 8 company sites, 170+ plants equipped, and 2,500+ serialization and aggregation lines, indicating strong global coverage and large enterprise demand for scalable traceability and inspection solutions.

Pharma focus Focused on pharmaceuticals, medical devices, cosmetics, and high‑regulatory industries, offering end‑to‑end protection of products through life‑cycle tracking and smart data management, presenting cross‑sell opportunities to pharma and biotech customers seeking compliance and efficiency.

Proven scale wins Over 5 billion products serialized globally and 20,000 inspection systems installed, demonstrating a compelling track record that can be leveraged to win adjacent contracts and renewals in large supply chains.

Innovation pipeline Recent launches and partnerships—AI driven blister inspection with IMA, laser spectroscopy leak detection, automatic visual inspection for prefilled syringes, and compact Easy TB unit—signal ongoing tech upgrades ripe for upsell to existing customers and entry to new use cases.

Financial and credibility signals Revenue scale in the hundred‑million range with substantial funding and high‑profile, multinational pharma audits support credibility for enterprise deals and can help in securing larger multi‑site contracts and long‑term service agreements.